Showing BioInteractions for Butamben (DB11148)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Butamben is a Voltage-dependent calcium channel inhibitor | ||
| 1 | Voltage-dependent calcium channel inhibitors | Enflurane, Spironolactone |
| 2 | Voltage-dependent calcium channel agonists | Bioallethrin |
| 3 | Voltage-dependent calcium channel inducers | Ergocalciferol |
| 4 | Voltage-dependent calcium channel activators | Enflurane |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Butamben is a ATP-sensitive potassium channel antagonist | ||
| 1 | ATP-sensitive potassium channel inhibitors | Yohimbine |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Butamben is a Transient receptor potential cation channel subfamily A member 1 inhibitor | ||
| 1 | Transient receptor potential cation channel subfamily A member 1 inducers | Levomenthol |
| 2 | Transient receptor potential cation channel subfamily A member 1 agonists | Cannabidiol, Cannabidivarin, Tetrahydrocannabivarin |
| 3 | Transient receptor potential cation channel subfamily A member 1 inhibitors | (S)-camphor, Camphor |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Butamben is a Transient receptor potential cation channel subfamily V member 4 inhibitor | ||
| 1 | Transient receptor potential cation channel subfamily V member 4 activators | Cannabidiol |